Last reviewed · How we verify

NCT03705923

Effect of Bariatric Surgery on Brain Insulin Sensitivity

Terminated NA Last updated 5 January 2022
What this trial tests

NA trial testing Bariatric surgery in Obesity in 3 participants. Terminated before completion.

Timeline
1 December 2018
Primary endpoint
1 December 2020
1 December 2020

Quick facts

Lead sponsorUniversity Hospital Tuebingen
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposebasic science
Enrollment3
Start date1 December 2018
Primary completion1 December 2020
Estimated completion1 December 2020
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital Tuebingen

Who can join

Adults 18 to 75, any sex, with Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Adiposity is associated with prediabetes and type 2 diabetes. In very severe cases of adiposity in combination with type 2 diabetes, bariatric surgery has proven to be a successful therapy option. So far the molecular mechanisms that lead to an improvement of type 2 diabetes after bariatric surgery are not fully understood. It is planned to characterize the metabolic and neuroendocrine changes in subjects before and after bariatric surgery. One special focus of the study is brain insulin resistance, a condition known to be associated with obesity with impact on the brain and whole body metabolism.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Bariatric surgery

Trials testing the same drug.

Other recruiting trials for Obesity

Currently open trials in the same condition.

Other University Hospital Tuebingen trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03705923.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing